More recently the Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) together with Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) were introduced as clinically highly sensitive and specific AKI biomarkers. This evidence concerns the gene IGFBP7 and acute kidney injury.